March 7, 2019 / 4:14 AM / 13 days ago

BUZZ-India's Biocon hits over 2-wk low; plant gets observations from U.S. FDA

** Biopharmaceutical company Biocon Ltd’s shares fall as much as 3 pct to 607.05 rupees, their biggest intraday pct loss since Feb. 15

** Co’s Bengaluru-based insulin drug substance manufacturing facility gets six Form 483 observations from U.S. FDA, Biocon said on Wednesday

** The FDA Form 483 notifies a company’s management of objectionable conditions

** More than 1.5 mln shares change hands, compared with 30-day average volume of around 1.4 mln shares

** Stock hits its lowest level since Feb. 19

** Stock down 0.47 pct this year, as of last close

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below